4-Chlorophenylguanidine hydrochloride Size:Contact [email protected] for quotation Smiles: NC(=N)NC1C=CC(=CC=1)C(=O)NCCC[C@H]1C(=O)N(CC(O)=O)CCN1C(=O)CNC(=O)C1C=CC(=CC=1)NC(N)=N

Smiles: NC(=N)NC1C=CC(=CC=1)C(=O)NCCC[C@H]1C(=O)N(CC(O)=O)CCN1C(=O)CNC(=O)C1C=CC(=CC=1)NC(N)=N

A study of the scheduling of Banoxantrone (AQ4N) administration shows that there is a very long time period over which a maximal effect can be elicited (drug given 4 days before to 6 h after radiation)

5-a]pyrimidin-7-amine

4-dimethoxyphenethyl)(methyl)amino)-2-(3

the effect of microiontophoretically applied 5-HT is prolonged and reaches statistical significance at 7

4-Chlorophenylguanidine hydrochloride Size:Contact [email protected] for quotation Smiles: NC(=N)NC1C=CC(=CC=1)C(=O)NCCC[C@H]1C(=O)N(CC(O)=O)CCN1C(=O)CNC(=O)C1C=CC(=CC=1)NC(N)=N4 Chlorophenylguanidine hydrochloride is a potent and selective inhibitor of urokinase . Urokinase is a serine protease. Its primary physiological substrate is plasminogen, which is an inactive form of plasmin. Urokinase plays an important role in vascular diseases and cancer. 4 Chlorophenylguanidine hydrochloride inhibited urokinase and trypsin with Ki value of 6. 07 M and 120 M, respectively . Product information CAS Number: 14279 91 5 Molecular